|
|
.
See Category: Neoplasms
See Header: Multiple myeloma
ICD-10 (CM) Code and Descriptor
|
C90.00 |
Multiple myeloma not having achieved remission
|
C9000 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 55.43%
|
29.39%
|
7.60%
|
2.78%
|
1.54%
|
1.11%
|
0.67%
|
0.42%
|
0.32%
|
0.20%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C90.00*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
241,949
|
242,122
|
|
80053
|
COMPREHEN METABOLIC PANEL |
220,797
|
220,815
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
182,682
|
183,322
|
|
82784
|
ASSAY IGA/IGD/IGG/IGM EACH |
179,639
|
378,653
|
|
83883
|
ASSAY NEPHELOMETRY NOT SPEC |
157,091
|
233,306
|
|
84165
|
PROTEIN E-PHORESIS SERUM |
140,327
|
140,357
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
128,654
|
129,033
|
|
86334
|
IMMUNOFIX E-PHORESIS SERUM |
96,867
|
97,316
|
|
J9041
|
INJECTION, BORTEZOMIB, 0.1MG |
70,743
|
1,325,725
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
67,599
|
67,625
|
|
96401
|
CHEMO ANTI-NEOPL SQ/IM |
59,870
|
64,250
|
|
83520
|
IMMUNOASSAY QUANT NOS NONAB |
53,235
|
75,027
|
|
83735
|
ASSAY OF MAGNESIUM |
52,280
|
52,392
|
|
84100
|
ASSAY OF PHOSPHORUS |
42,189
|
42,211
|
|
82232
|
ASSAY OF BETA-2 PROTEIN |
41,704
|
41,735
|
|
84155
|
ASSAY OF PROTEIN SERUM |
33,514
|
33,543
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
32,774
|
32,780
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
30,592
|
34,358
|
|
85027
|
COMPLETE CBC AUTOMATED |
24,533
|
24,657
|
|
J9144
|
DARATUMUMAB, HYALURONIDASE |
23,537
|
4,175,165
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C90.00 related to the following DRG Codes:
820-822
823-825
840-842
|
